Virologica Sinica

, Volume 33, Issue 4, pp 378–381 | Cite as

Serological Cross Reactivity between Zika and Dengue Viruses in Experimentally Infected Monkeys

  • Shailendra Mani
  • Chee Wah Tan
  • Lin-Fa Wang
  • Danielle E. Anderson

Dear Editor,

Zika virus (ZIKV), a pathogen within the genus Flavivirus, family Flaviviridae brought an international public health emergency due to its association with neonatal microcephaly case (Platt and Miner 2017). Currently the most reliable diagnostic test is PCR detection of ZIKV RNA from body fluid samples. Unfortunately, the short viremia window and asymptomatic/mild infections greatly reduce the success rate of PCRs (de Vasconcelos et al.2018). Serological assays play a pivotal role in retrospective diagnosis of ZIKV infection, especially for pregnant women concerned about ZIKV infection during their early stages of pregnancy (de Vasconcelos et al.2018). However, due to the high level of cross reactivity among related flaviviruses, all serology tests conducted in locations where flaviviruses co-circulate prove to be difficult for making a conclusive diagnosis, especially for diagnosis of ZIKV infection in dengue virus (DENV) pre-exposed individuals (David et al.2017;...



We thank Edgar Macabe Pena and his team, especially Ryan Cabo Maniquiz and Redmond Belen Cheng, for assistance with monkey infection studies. We thank Veronika von Messling for providing expertise and assistance in planning of the animal studies, and Eng Eong Ooi and his lab members, especially Eugenia Ong and Esther Gan, for providing DENV2 viruses. The project was funded in part by NMRC Grant ZRRF16006 and CD-PHRG Grant CDPHRG/0006/2014.

Compliance with Ethical Standards

Conflicts of interest

The authors declare that there are no conflicts of interest.

Animal and Human Rights Statement

Cynomolgus macaques (Macaca fascicularis) were used for all studies. The experiments were approved by the SingHealth Institutional Animal Care and Use Committee of the SingHealth Experimental Medicine Centre (SEMC).

Supplementary material

12250_2018_48_MOESM1_ESM.pdf (314 kb)
Supplementary material 1 (PDF 315 kb)


  1. Balmaseda A, Stettler K, Medialdea-Carrera R, Collado D, Jin X, Zambrana JV, Jaconi S, Cameroni E, Saborio S, Rovida F, Percivalle E, Ijaz S, Dicks S, Ushiro-Lumb I, Barzon L, Siqueira P, Brown DWG, Baldanti F, Tedder R, Zambon M, de Filippis AMB, Harris E, Corti D (2017) Antibody-based assay discriminates Zika virus infection from other flaviviruses. Proc Natl Acad Sci USA 114:8384–8389CrossRefPubMedGoogle Scholar
  2. Bardina SV, Bunduc P, Tripathi S, Duehr J, Frere JJ, Brown JA, Nachbagauer R, Foster GA, Krysztof D, Tortorella D, Stramer SL, Garcia-Sastre A, Krammer F, Lim JK (2017) Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science 356:175–180CrossRefPubMedPubMedCentralGoogle Scholar
  3. Collins MH, McGowan E, Jadi R, Young E, Lopez CA, Baric RS, Lazear HM, de Silva AM (2017) Lack of durable cross-neutralizing antibodies against Zika virus from dengue virus infection. Emerg Infect Dis 23:773–781CrossRefPubMedPubMedCentralGoogle Scholar
  4. David S, Angela S, Derek RS, Emelissa M, Nicole B, Charlene R, Leanne S, Kimberly H, Alyssia R, Maya T-A, Kai M, Kristina D, Elizabeth G, Joanne H, Rhonda M, Sharla B, Michael D (2017) Evaluation of 5 commercially available Zika virus immunoassays. Emerg Infect Dis 23:1577CrossRefGoogle Scholar
  5. de Vasconcelos ZFM, Azevedo RC, Thompson N, Gomes L, Guida L, Moreira MEL (2018) Challenges for molecular and serological ZIKV infection confirmation. Childs Nerv Syst 34:79–84CrossRefPubMedGoogle Scholar
  6. Guzman MG, Alvarez M, Halstead SB (2013) Secondary infection as a risk factor for dengue hemorrhagic fever/dengue shock syndrome: an historical perspective and role of antibody-dependent enhancement of infection. Arch Virol 158:1445–1459CrossRefPubMedGoogle Scholar
  7. Jelsma T, van der Wal FJ, Fijten H, Dailly N, van Dijk E, Loeffen WL (2017) Pre-screening of crude peptides in a serological bead-based suspension array. J Virol Methods 247:114–118CrossRefPubMedGoogle Scholar
  8. L’Huillier AG, Hamid-Allie A, Kristjanson E, Papageorgiou L, Hung S, Wong CF, Stein DR, Olsha R, Goneau LW, Dimitrova K, Drebot M, Safronetz D, Gubbay JB (2017) Evaluation of euroimmun anti-Zika virus IgM and IgG enzyme-linked immunosorbent assays for Zika virus serologic testing. J Clin Microbiol 55:2462–2471CrossRefPubMedPubMedCentralGoogle Scholar
  9. Platt DJ, Miner JJ (2017) Consequences of congenital Zika virus infection. Curr Opin Virol 27:1–7CrossRefPubMedGoogle Scholar
  10. Priyamvada L, Quicke KM, Hudson WH, Onlamoon N, Sewatanon J, Edupuganti S, Pattanapanyasat K, Chokephaibulkit K, Mulligan MJ, Wilson PC, Ahmed R, Suthar MS, Wrammert J (2016) Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci USA 113:7852–7857CrossRefPubMedGoogle Scholar
  11. Shan C, Xie X, Ren P, Loeffelholz MJ, Yang Y, Furuya A, Dupuis AP II, Kramer LD, Wong SJ, Shi PY (2017) A rapid Zika diagnostic assay to measure neutralizing antibodies in patients. EBioMedicine 17:157–162CrossRefPubMedPubMedCentralGoogle Scholar
  12. Wong SJ, Furuya A, Zou J, Xie X, Dupuis AP II, Kramer LD, Shi PY (2017) A multiplex microsphere immunoassay for Zika virus diagnosis. EBioMedicine 16:136–140CrossRefPubMedPubMedCentralGoogle Scholar
  13. Xu GJ, Kula T, Xu Q, Li MZ, Vernon SD, Ndung’u T, Ruxrungtham K, Sanchez J, Brander C, Chung RT, O’Connor KC, Walker B, Larman HB, Elledge SJ (2015) Viral immunology. Comprehensive serological profiling of human populations using a synthetic human virome. Science 348:aaa0698CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Wuhan Institute of Virology, CAS and Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  1. 1.Programme in Emerging Infectious DiseasesDuke-NUS Medical SchoolSingaporeSingapore

Personalised recommendations